XBiotech, Inc. IPO Research Information

XBiotech, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on XBiotech, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
XBiotech, Inc.	XBIT - NASDAQ	$18.00-$20.00	$19.00	$23.00	4 million	4/15/2015
Underwriter(s): WRHambrecht + Co.
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2015-02-02 Terms Added 2015-03-10

XBiotech, Inc. Quote & Chart - Click for current quote - XBIT

About XBiotech, Inc. (adapted from XBiotech, Inc. prospectus):
IPO is being marketed as a best efforts offering. XBiotech is a clinical-stage biopharmaceutical company engaged in discovering and developing "True Human" monoclonal antibodies for treating a variety of diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "XBIT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.